AVEIR™ VR Leadless Pacemaker’s
helical fixation is designed for
long term retrieval, expanding
Battery has up to twice the capacity of other leadless pacemakers on the market.1,3
AVEIR™ VR Leadless Pacemaker mapping capability is designed to help reduce the number of
Should new pacing indications present, the software for AVEIR VR Ventricular LP is designed to pair with AVEIR AR Atrial LP, allowing the devices to upgrade to an AVEIR DR Dual Chamber Leadless Pacemaker System.1**
AVEIR VR LP is MR Conditional for full body scans using a 1.5T or 3T field strength MRI scanner.***
*The AVEIR™ VR Leadless Pacemaker’s predicate device has a overall long-term retrieval success rate above 88% with helix fixation with up to 9 years of retrieval experience. AVEIR VR LP is designed for long-term retrieval. Limited data is available for the AVEIR VR LP.2
** AVEIR AR Atrial Leadless Pacemaker System and AVEIR DR Dual Chamber Leadless Pacemaker system are commercially approved for use only in the USA market at this time. The AVEIR AR and DR systems are currently under review and pending CE mark.
*** Stability of pacing capture thresholds is required prior to MRI scan. For additional information about specific MR Conditional, including warnings, precautions, adverse conditions to MRI scanning and potential adverse events, please refer to the MRI-Ready Leadless Systems Manual at medical.abbott/manuals or check our MRI Ready resources at cardiovascular.abbott/mriready.
MAT-2310177 v1.0 | Item approved for global use. Product not approved in all geographies.
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?